Regavirumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Regavirumab
Monoclonal antibody
Type Whole antibody
Source Human
Target cytomegalovirus glycoprotein B
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
 NYesY (what is this?)  (verify)

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References[edit]

  1. ^ Arizono, H; Sugano, T; Kaida, S; Shibusawa, K; Karasawa, Y; Esumi, Y; Kondo, S; Kiyoki, M (1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.